Laxmi India Finance IPO Day 1 Live: Check GMP, key dates, review, subscription status, more
Funds raised from the fresh issue will be allocated to enhance its capital base to satisfy future lending requirements and for general corporate activities.
As a non-deposit-taking NBFC, Laxmi India Finance provides a variety of financial products, such as loans for MSMEs (micro, small and medium enterprises), vehicle financing, construction loans, and other lending services.
By March 2025, the company's assets under management (AUM) rose to ₹ 1,277 crore from ₹ 687 crore as of March 2023, indicating a compound annual growth rate (CAGR) exceeding 36 percent, largely fueled by higher loan volumes and an improved branch network.
Stay tuned for more updates
Follow updates here:
29 Jul 2025, 09:01 AM IST
Laxmi India Finance IPO has reserved not more than 50% of the shares in the public issue for qualified institutional buyers (QIB), not less than 15% for non-institutional Institutional Investors (NII), and not less than 35% of the offer is reserved for retail investors. The employee portion has been reserved upto 160,928 equity shares.
29 Jul 2025, 09:01 AM IST
Laxmi India Finance successfully secured more than ₹ 75 crore from anchor investors on Monday, prior to the opening of its initial public share subscription.
This portion intended for anchor investors included participation from various institutional investors, such as Saint Capital Fund, BNP Paribas Financial Markets -- ODI, Compact Structure Fund, Cognizant Capital Dynamic Opportunities Fund, India Max Investment Fund, Holani Venture Capital Fund-I, and Rajasthan Global Securities, as detailed in a circular published on the BSE website.
According to the circular, Laxmi India Finance has issued 47.79 lakh equity shares to 11 funds at a price of ₹ 158 each, resulting in a total transaction value of ₹ 75.51 crore.
29 Jul 2025, 08:59 AM IST
Laxmi India Finance IPO GMP is +9. This indicates Laxmi India Finance share price was trading at a premium of ₹ 9 in the grey market, according to investorgain.com.
Considering the upper end of the IPO price band and the current premium in the grey market, the estimated listing price of Laxmi India Finance share price was indicated at ₹ 167 apiece, which is 5.70% higher than the IPO price of ₹ 158.
According to the analysis of the past eight sessions of grey market activities, today's IPO GMP is on the rise and is anticipated to have a robust listing. The minimum GMP recorded is ₹ 0.00, whereas the maximum GMP stands at ₹ 18, as reported by experts from investorgain.com.
'Grey market premium' indicates investors' readiness to pay more than the issue price.
Disclaimer: The views and recommendations above are those of individual analysts, experts and broking companies, not of Mint. We advise investors to check with certified experts before making any investment decision.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Standard
22 minutes ago
- Business Standard
Puraniks to Launch India's Tallest Thematic Tower for Middle Income Homebuyers
PNN Mumbai (Maharashtra) [India], August 2: In a bold move that could redefine urban housing for middle-income families, Puraniks has announced the launch of India's tallest thematic residential tower, a 50-storey skyscraper on Ghodbunder Road, Thane, tailored for the ₹50 lakh to ₹1 crore homebuyer. For the first time in the country, a structure of such height will pair global architectural themes with accessible price points, a format typically associated with high-end luxury developments. With smartly designed 1 and 2 BHKs, along with flexible jodi options, the project is targeted at salaried professionals and first-time homebuyers looking to upgrade their lifestyle without crossing into premium segments. Shailesh Puranik, Managing Director, Puranik Builders, stated: "We're building more than the tallest tower on Ghodbunder Road. We're setting a national benchmark where ambition, elegance, and affordability can coexist. For too long, skyscraper living was a luxury dream for the few. We're here to change that." Located in the rapidly growing Kavesar-Gaimukh zone, the tower is poised to become a defining icon of Ghodbunder Road, a corridor increasingly seen as the MMR's most inclusive housing destination. Property values in the area have more than doubled over the past decade, from ₹6,400 per sq. ft. in 2014 to ₹13,800 to ₹18,000 in 2024 (CRE Matrix), while remaining far more affordable than the MMR average. In FY 2024-25, 81% of buyers in the belt declared self-use, with residential sales rising over 28%. With a track record of delivering 7.5 million sq. ft. and housing over 9,000+ families in the Ghodbunder belt, with this launch, Puraniks Group is deepening its focus on bold vertical developments that cater to India's aspiring middle class, combining scale, design, and smart urban living. "There are taller buildings in India. And there are themed buildings. But there has never been a themed skyscraper created for the ₹70 lakh buyer," said a senior Mumbai-based property consultant. "This project marks a new era of vertical democratisation of aspiration." With key infrastructure upgrades underway, including Metro Line 4, the Borivali Thane tunnel, and a proposed coastal arterial link, Ghodbunder Road is emerging as MMR's best-connected, future-ready residential corridor.
Business Standard
22 minutes ago
- Business Standard
Rajasthan Aushdhalaya Pvt. Ltd. Reaches ₹2000 Crore Net Worth
VMPL New Delhi [India], August 2: Rajasthan Aushdhalaya Pvt. Ltd. (RAPL Group), a pioneer in the Ayurvedic nutraceutical sector, has achieved a significant milestone by surpassing a net worth of ₹2000 crore. This achievement is not merely a financial benchmark--it reflects the growing confidence in Ayurveda as a credible health system that harmoniously blends ancient wisdom with modern therapeutic technologies. Global Recognition and Validation In a recent development, the Dubai-based investment firm Refasa formally recognized Rajasthan Aushdhalaya Pvt. Ltd. as one of India's most ideal and high-performing companies. Refasa's independent audit confirmed RAPL's net worth at ₹2000 crore, positioning it among the top Ayurvedic and nutraceutical companies in the country. RAPL's high net worth stands out, especially when compared to similar companies, further underscoring its credibility and sustained growth. With over 20 million patients treated across India, this recognition affirms RAPL's financial transparency, operational excellence, and consumer trust. The company proudly collaborates with over 65,000 doctors operating from their own clinics across India--from Kashmir to Kanyakumari, and Gujarat to Arunachal Pradesh--making it the only Ayurvedic company with such an extensive clinical outreach. From Vision to National Mission Founded with a mission to mainstream Ayurveda through scientific validation and contemporary formulations, RAPL has evolved from humble beginnings into a household name in holistic wellness. With a diverse portfolio of over 400 Ayurvedic and nutraceutical products, RAPL has touched millions of lives, both in India and globally. Its comprehensive product line offers effective solutions for: - Immunity and immune enhancement - Metabolic and lifestyle disorders - Gastrointestinal health - Women's wellness This strategic focus has firmly established RAPL as a leader in preventive and holistic healthcare. Dynamic Leadership and Innovation Under the leadership of Mr. Salim Diwan, Managing Director of RAPL, the company has achieved numerous milestones, including the establishment of a state-of-the-art manufacturing unit in Rajasthan. Speaking on this milestone, Mr. Diwan said: "This isn't just a financial achievement--it's a milestone of trust. Our journey has been driven by the faith people have placed in us. 'Rog Mukt Bharat, Nasha Mukt Bharat' is not merely a slogan; it defines our core purpose. We aim to integrate the timeless principles of Ayurveda with the precision of modern science to offer natural, affordable, and reliable healthcare." A Bollywood actor and entrepreneur, Mr. Diwan is a passionate advocate for Ayurveda as a tool for public health. His vision has led RAPL to spearhead initiatives such as: - Rural health outreach - Ayurveda education campaigns - Free mobile health units - Digital healthcare platforms These efforts have significantly increased public access to natural healthcare solutions. Global Expansion and Cutting-Edge R & D RAPL continues to invest heavily in research and development, quality control, and innovative product development. All formulations adhere to stringent international quality and safety standards, ensuring efficacy, consistency, and global compliance. With a growing international footprint, RAPL now operates in over 22 countries, including major markets across Europe, the Middle East, and Southeast Asia. The company is at the forefront of transforming Ayurveda from an alternative therapy to an evidence-based, globally accepted healthcare system. Strategic Vision for the Future Looking ahead, RAPL's growth is anchored in a purposeful vision to address the evolving healthcare needs of diverse populations. Key initiatives include: - Strongly countering addiction through Ayurveda - Enhancing women's health and mental well-being - Developing advanced sports nutrition and fitness supplements - Innovating senior health solutions with targeted formulations - Creating diagnostic and wellness programs based on personalized Ayurvedic principles - Collaborating with global universities and research institutions to further validate and promote Ayurvedic science A Celebration of Heritage, Science, and Well-being Surpassing the ₹2000 crore net worth is more than a financial victory--it symbolizes a resurgence of India's cultural and medicinal heritage. In an era where consumers are actively seeking sustainable, preventive, and natural healthcare options, Rajasthan Aushdhalaya Pvt. Ltd. stands at the forefront of an Ayurvedic renaissance. With a firm commitment to "Rog Mukt Bharat, Nasha Mukt Bharat," RAPL is not just creating products--it is cultivating a movement. A movement that repositions Ayurveda as a globally trusted system of wellness, with India leading the way.
Time of India
22 minutes ago
- Time of India
ETtech Deals Digest: Startups raise $126 million this week, down 35% on-year
ETtech ETtech Academy Empower your mind, elevate your skills ETtech ETtech Startups raised around $125.7 million during the week of July 26 to August 1, marking a 34.6% decline from the $192.1 million raised during the same period last year, according to data from funding amount declined from the previous week as well, dropping 40.5% from $211.3 activity, too, declined this week on a year-on-year (YoY) basis, with 17 transactions recorded during the period, compared to the 45 deals seen in the corresponding week last intelligence startup Safe Security raised $70 million in a funding round led by Avataar Ventures, with participation from Susquehanna Asia Venture Capital, NextEquity Partners, and Prosperity7 kitchen operator EatClub, which runs brands like Box8 and Mojo Pizza, raised around $22 million in funding led by existing investors Tiger Global, A91 Partners, and 360 One Asset Management. Metaforms raised $9 million in a funding round led by Peak XV Partners, with Nexus Venture Partners and Together Fund gaming platform Stan raised $8.5 million in a funding round from a clutch of investors, including Japanese gaming firms, Google, and Nazara Technologies Edtech startup Arivihan, which offers automated, personalised coaching for school students, raised $4.17 million in a funding round led by Dutch investment firm Prosus and Silicon Valley-based venture capital (VC) firm Accel
